|
Creation of a technological plateform for the administration of medicines by pulmonary route
Key words: drug delivery, medical device, inflammation
Consortium
Companies: UCB (Coordinator), Optim Test Center, Techno Consulting, Cosysys
Research Centers: ULg (Cyclotron Research Center), ULg (Pharmaceutical technology),
ULg (Pulmonary molecules and cells), ULB (Pharma & Biopharma), ULB – NMI (Nuclear Medical Imaging / School of Medicine ), ULB - BEAMS (Bio-Electric and Mechanic Systems / Faculty of applied sciences)
Topic of the project
The aim of NEOFOR project is to establish in Wallonia a consortium who will coordinate multidisciplinary and of technologies groups in order to construct a new SME that will be able – when created – to propose the conception and materialization of original formulations compiled with new medical devices for pulmonary drug administration. The long-term aim is the development and the production following Good Manner of Production of formulation for original molecules a well as appropriated medical devices for the pulmonary delivery of high mass molecular molecules, that is to say proteins, hormones and monoclonal antibodies allowing an innovating therapeutic approach for the treatment of the lung cancer and inflammation diseases.
At the end, the project will create a platform getting together the expertise of centers, university labs, small or big and pharmaceutical industries which own different qualifications and that will materialize a new small society (a “start-up”) in charge of the coordination of studies in order to reach this aim.
Budget
This is a 4-year project with a total budget of M€ 4.5.
Contact
Phil Goliber / Domenico Fanara (Coordinator of the project)
Email: Domenico.Fanara@ucb.com
UCB S.A.
Website: http://www.ucb.com
|
|
|
|